Alphabetically   > S   > Silence Therapeutics plc  

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
 
 

Silence Therapeutics plc

transparent spacer
transparent spacer
transparent spacer

Company Information

Address:

The Royal Institute of Great Britain
21 Albermarle Street
London
W1S 4BS

Tel:

+44 (0) 20 7491 6521

Fax:

+44 (0) 20 7491 6521

E-Mail:

Secretary:

Melvyn Davies

Registrar:

Capita Registrars Beckenham Ltd

Company Overview

Silence Therapeutics is the leading RNAi therapeutics company in Europe. The Company has developed novel, proprietary short interfering RNA (“siRNA”) molecules. These molecules provide a number of advantages over conventional siRNA molecules as they show increased stability against nuclease degradation. In addition, the Company has developed a proprietary systemic delivery system, AtuPLEX. This enables the delivery of siRNA molecules to targeted diseased tissues and cells in the body, whilst increasing their bioavailability and circulation times.

Interim Reports

Description Report Date Published
Interim Results 2011 in PDF * 30/06/2011 21/09/2011
Interim Results 2010 in PDF 30/06/2010 20/09/2010
Interim Results 2009 in PDF 30/06/2009
Interim Results 2009 in PDF 30/06/2009
Interim Results 2008 in PDF 30/06/2008 24/09/2008
Interim Results 2007 in PDF 30/06/2007 27/09/2007
 
Other Links
Description
bullet point Home
bullet point Investor Relations
bullet point Press Releases
bullet point Contacts
A B C D E F G H I J K L M
N O P Q R S T U V W X Y Z